The popularity of peptide therapies has surged in recent years. As a plastic surgeon working in regenerative medicine for more than two decades, I have watched public interest in treatments that promise to optimise healing, improve recovery and potentially influence aspects of biological ageing grow. While some peptide therapies have genuine medical value, many claims currently being made in the wellness industry are running ahead of the evidence.
However, as interest in peptide therapies grows, so does the need for clarity. While some peptides have transformed modern medicine and are supported by robust scientific evidence, many claims circulating in the wellness industry remain ahead of the available research.
Understanding the difference between clinically validated therapies and experimental treatments is essential for anyone considering the use of peptides.
What Are Peptides?
Peptides are short chains of amino acids that act as biological messengers in the body. By binding to receptors on cells, they can instruct tissues to perform specific functions, such as producing collagen, releasing hormones, regulating appetite, or supporting repair processes.
Because they influence biological activity in highly targeted ways, peptides have become valuable tools in modern medicine. Certain peptide-based therapies are now routinely used to treat a range of medical conditions and have demonstrated significant benefits in carefully controlled clinical settings.
One of the most notable examples is the development of GLP-1 receptor agonists, which help regulate appetite and blood sugar levels and have transformed the treatment of obesity and type 2 diabetes. Other peptide therapies are used in endocrinology to address hormonal disorders and deficiencies.
The success of these medically approved treatments has fuelled growing interest in whether peptides might also play a role in longevity and healthy ageing.
Why Are Peptides Used in Longevity Medicine?
Within the longevity sector, peptides are often marketed as tools for enhancing fat metabolism, improving muscle recovery, supporting tissue repair, optimising hormone function and slowing aspects of biological ageing.
The theory behind many of these treatments is scientifically plausible. Ageing is associated with declining cellular repair mechanisms, reduced collagen production, hormonal changes and increased inflammation. Because peptides can influence these processes, researchers have explored whether they might support healthier ageing.
However, while the biological rationale is often compelling, scientific plausibility is not equivalent to clinical proof.
Many longevity-focused peptide therapies remain experimental, with evidence for their use varying in strength.
The Most Commonly Discussed Peptides
Two peptides frequently promoted within the wellness and performance space are BPC-157 and CJC-1295.
BPC-157
BPC-157, or Body Protection Compound-157, is a synthetic peptide derived from a naturally occurring protein found in gastric juice.
It is commonly marketed for tissue repair, particularly in relation to tendons, ligaments and the gastrointestinal tract. Research in animal models has suggested that it may promote healing, reduce inflammation and support tissue regeneration.
However, the majority of supporting evidence comes from laboratory and animal studies. Robust human clinical trials remain limited, and BPC-157 has not been approved for routine medical use.
CJC-1295
CJC-1295 is designed to stimulate growth hormone release by acting on the pituitary gland.
For this reason, it is often promoted as a means of increasing muscle mass, reducing body fat and enhancing recovery. While its mechanism of action is scientifically understood, long-term safety data in healthy individuals remain limited.
Its use outside regulated medical settings remains controversial, particularly given the broader systemic effects associated with growth hormone stimulation.
These examples highlight a broader issue in the peptide market: many compounds are biologically active and may produce measurable effects, but they have not yet undergone the level of clinical scrutiny required for widespread or unsupervised use.
Can We Obtain Peptides from the Diet?
Peptides occur naturally in many foods, leading some people to wonder whether dietary sources can provide benefits comparable to those of therapeutic peptide treatments.
The answer is both yes and no.
When we consume protein-rich foods, the digestive system breaks proteins down into amino acids and small peptide fragments. These building blocks are then used by the body to create its own hormones, enzymes and structural proteins.
Certain foods contain naturally occurring bioactive peptides that may support overall health. Collagen-rich broths, dairy products and fermented foods have all been studied for their potential physiological benefits.
However, these naturally occurring dietary peptides are fundamentally different from therapeutic peptides designed to elicit specific biological responses. While nutrition provides the raw materials the body needs, it does not deliver the same targeted effects as medically developed peptide therapies.
In essence, diet supports the body's ability to produce peptides rather than acting as a substitute for therapeutic peptide treatment.
How Are Peptides Used in Anti-Ageing Medicine?
The method of delivery depends largely on the intended purpose of the peptide.
Topical Peptides
Peptides have become increasingly common ingredients in advanced skincare products. These formulations are often designed to stimulate collagen production, support skin repair and improve overall skin quality.
Topical peptides are generally considered low-risk and widely used in cosmetic dermatology.
Oral Peptides
Oral peptide therapies are less common because many peptides are unstable within the digestive tract. Enzymes in the stomach and intestines often break them down before they can exert meaningful biological effects.
Injectable Peptides
Injectable peptides are typically administered subcutaneously and are intended to produce broader systemic effects throughout the body.
These treatments are increasingly offered by longevity and regenerative medicine clinics. However, because injectable peptides influence biological processes beyond the skin, they should only be used under appropriate medical supervision.
Is There Evidence That Peptides Slow Ageing?
This remains one of the most important questions in longevity medicine. At present, there is limited high-quality evidence demonstrating that peptides can broadly slow human ageing.
While certain peptides have proven benefits in specific medical conditions, much of the enthusiasm surrounding anti-ageing applications is based on:
- Laboratory research
- Animal studies
- Small clinical trials
- Theoretical biological mechanisms
This does not necessarily mean that peptides are ineffective. Rather, it means that many of the claims currently being made exceed the strength of the available evidence. Longevity medicine is a rapidly evolving field, and more robust human studies are needed before definitive conclusions can be drawn.
Understanding the Potential Risks
As with any biologically active therapy, peptide use carries potential risks.
The safety profile depends on the specific peptide being used, how it is administered and the individual patient's medical history.
Potential concerns may include hormonal disruption, particularly with growth hormone-stimulating peptides. Some compounds may contribute to fluid retention, cardiovascular strain or alterations in glucose metabolism.
Injectable therapies also carry practical risks, including infection, tissue irritation and complications related to improper administration. Perhaps the greatest concern is the lack of long-term safety data for many peptides currently being promoted in the wellness market. Without large-scale human studies, it remains difficult to fully understand their long-term effects.
This issue is compounded by the increasing availability of peptides from unregulated suppliers, in which product quality, purity, and sterility may not be adequately controlled.
Could Peptides Increase Cancer Risk?
One question frequently raised by both patients and clinicians is whether peptides that stimulate cellular growth and repair could potentially encourage tumour development.
This is a complex issue.
Many regenerative processes involve increased cellular activity, tissue repair and the formation of new blood vessels. These mechanisms are beneficial when supporting healing and regeneration. However, similar biological pathways can also contribute to tumour growth.
At present, there is no definitive clinical evidence demonstrating that commonly used peptides directly cause cancer. Equally, there is insufficient long-term research to completely exclude potential risks, particularly in individuals with existing or undiagnosed malignancies. For this reason, careful patient selection and medical oversight remain essential whenever biologically active therapies are being considered.
A Balanced Approach to Peptide Therapy
Peptides represent one of the most fascinating and potentially transformative areas of modern medicine. Their ability to influence highly specific biological processes offers exciting possibilities across endocrinology, regenerative medicine and targeted therapeutics.
However, the rapid growth of the wellness and anti-ageing market has, in many cases, outpaced the science.
A clear distinction must be drawn between peptide therapies validated by rigorous clinical research and those that remain experimental. While some peptides have established medical applications, others are still under investigation and should be approached with appropriate caution.
From a regenerative and surgical perspective, peptides should be treated like any other biologically active treatment: evidence-led, carefully selected, and used under expert medical supervision.
As research continues to evolve, peptides may become an increasingly important part of personalised medicine and healthy ageing strategies. Until then, patients should remain informed, ask questions and seek guidance from experienced medical professionals rather than relying solely on marketing claims.
Read “Designer peptides for wellness: are they safe?” in the British Medical Journal: https://www.bmj.com/content/393/bmj.s924
